WMSA
ONCT

Weiss Multi-Strategy Advisers’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-43
Closed -$100K – 1148
2013
Q4 		$100K Buy
+43
New +$98.4K ﹤0.01% 945
2013
Q3 		– Sell
-121
Closed -$1.12M – 1021
2013
Q2 		$1.12M Buy
+121
New +$932K 0.03% 373

Other funds holding ONCT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ONCT Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q1 2014, closing a stake of 43 shares — an estimated $100K sold.

Weiss Multi-Strategy Advisers first reported a position in ONCT in Q2 2013 and held it in 2 quarters. The position peaked at $1.12M in Q2 2013. 55 funds tracked by Wall St. Rank hold ONCT as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 43 Oncternal Therapeutics, Inc. Common Stock shares in Q1 2014, an estimated $100K.
  • Weiss Multi-Strategy Advisers first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's Oncternal Therapeutics, Inc. Common Stock position peaked at $1.12M in Q2 2013.
  • 55 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.